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Abstract  
Background: Limb trauma is one the main causes of emergency room (ER) referrals and patients often 
complain of pain from the very moment of arrival. 
Objective: We decided to compare the analgesic effect of ketamine nebulizer with intravenous (IV) morphine 
in trauma patients referred to ER. 
Methods: In this clinical trial study trauma patients referred to ER of Alzahra and Kashani hospitals in Isfahan, 
Iran were selected. All trauma patients older than 18 years with limb pain who had a pain score ≥ 7 based on 
visual analogue scale (VAS) criteria were included. During pre-hospital management, patients were divided 
into two groups of receiving ketamine nebulizer with a dose of 1.6 mg/kg and receiving IV morphine with a 
dose of 0.1 mg/kg. Pain score, vital signs and complications were recorded 5 and 15 minutes after receiving 
the first dose of drug and also at the time of arrival to ER. 
Results: Finally, the records of 391 patients were analysed. There was no significant difference between the 
two groups in terms of pain intensity, vital signs before intervention, the first 5 and 15 minutes after and the 
time of arrival in ER (P>0.05). But the changing of VAS scores in different times was significant in both groups 
(P<0.001). There was a significant difference between the two groups in complications including nausea and 
vomiting (P<0.001), and also delirium (P=0.010). 
Conclusion: Using ketamine nebulizer can produce similar analgesic effects as IV morphine in trauma patients 
referred to ER. 
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INTRODUCTION
The importance of pain as the most annoying 
complaint of trauma patients in ER has led pain 
control to be one of the top priorities of the health 
system dealing with trauma patients. Different 
drugs are used to control pain in trauma patients, 
opioids and especially morphine are still 
considered as the first line of treatment of pain in 
emergency rooms (1). Using opioids as an analgesic 
treatment can cause many complications and 
problems the most important of which is 
respiratory depression and even apnea. Also, due 
to higher risks of airways obstruction and 
aspiration pneumonia in trauma patients, nausea 
and vomiting after opioid administration has a 
significant higher risk (2). Therefore, it seems that 
safer methods should be applied to reduce pain in 
trauma patients. Ketamine is one of the drugs with 
analgesic characteristics which is soluble in water 
and fat and has different ways of administration (3, 
4). The analgesic effect of ketamine associated with 
its other characteristics are among the reasons why 
ketamine has been considered as a safe analgesic 
drug in recent years. Ketamine helps to calm 
patients by sedative and pain relieving effects and 
unlike opioids not only it does not cause 
respiratory depression, on the contrary it leads to 
bronchus dilation which can be very useful in 
trauma and pulmonary patient management. 
Different studies have been conducted on ketamine 
efficacy as an analgesic drug in ER and trauma 
patients which have pointed ketamine out as a safe 
and effective analgesic drug (5, 6). In previous 
studies respiratory depression, reduced 
respiratory capacity, nausea and vomiting were 
less frequently noted which distinguishes 
ketamine from opioids especially morphine. 
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According to the easier and more accessible ways 
of ketamine absorption in body, using ketamine 
nebulizer may be an efficient way to reduce pain in 
patients and prevent over-sedating (7). Therefore, 
due to the importance of pain control in trauma 
patients referred to emergency rooms and also use 
of different drugs with different side effects such as 
morphine, we decided to compare the analgesic 
effects of intravenous morphine with ketamine 




This randomized, double blinded, clinical trial was 
conducted in ER of Alzahra and Kashani hospitals, 
Isfahan province, Iran from 2017 to 2019. The 
protocol of present study was approved in medical 
ethics committee of Isfahan University of Medical 
Sciences (code: IR.MUI.REC.1396.3.457). After 
explaining the methods and purposes of the study, 
written consent forms were filled out by all the 
patients included in the study. The authors were 
fully adhered to declaration of Helsinki Principles 
throughout the study. 
Study population 
The sample size was calculated 180 patients in 
each group using mean differences formula with 
considering mean differences (pain) of 0.17, 
α=0.05, β=0.1, and differences of standard 
divisions of 0.24. Considering 9% loss, at least 200 
random samples from each of the two groups 
(ketamine and morphine) and a total of 400 
random samples should be studied to obtain a 90% 
probability of 24% difference was found in the 
standard deviation of pain on the visual analogue 
scale (VAS) scale with the first type error of 5%. 
The sampling was performed based on consecutive 
method. All the patients who had a pain score of 
seven or more based on VAS and were above the 
age of 18 were included in the study. However, 
patients with head trauma, coronary ischemic 
disease, acute cardiac and pulmonary failure, 
systolic blood pressure more than 180 mmHg or 
less than 90 mmHg, alcohol abuse, pulmonary 
failure, asthma, high intracranial pressure (ICP) 
symptoms, pregnancy, history of allergy to 
morphine or ketamine, prior administration of 
analgesics before admission, addiction, need to 
more than twice doses of analgesic drugs, 
contraindications for receiving ketamine or 
morphine, changing the sedative drugs during 
study, incapability of describing pain severity and 
incompetency to give informed consent were 
considered as exclusion criteria. Patients arriving 
to the hospital in less than thirty minutes were also 
excluded. Patients were divided randomly with 
using random allocation software into two groups 
as ketamine and morphine. Also the patients and 
resident or emergency medical technician (EMT) 
were blinded about group names. 
Intervention and data gathering 
All patients were visited by an emergency medicine 
resident and a trained EMT. The EMTs were trained 
by the main operator of the study on how to 
measure pain intensity using VAS, how to properly 
administer the drugs and their possible side effects 
and complications. These trainings took place in a 
workshop before the study began. Patients’ 
information was primarily collected through an 
interview performed by the EMTs and recorded in 
pre-made checklists. The checklist was included 
demographics, heart rate, blood pressure, 
respiratory rate, oxygen saturation percentage, 
consciousness level (based on Glasgow coma scale 
(GCS)), primary VAS, complications after drug 
administration (like nausea, vomiting, delirium), 
onset of analgesic effects and efficacy duration. 
Ketamine nebulizer was administered with a dose 
of 1.6 mg/kg and then was diluted with 5cc of 
sterile water. Morphine was administered 
intravenously (IV) with a dose of 0.1 mg/kg after 
being diluted with 5cc of sterile water. Patients 
received these drugs twice within 10 minutes and 
those who needed more than twice of drug doses 
were excluded.  
All the patients with an oxygen saturation 
percentage less than 92% received oxygen bag 
masks providing 4-6 liters of oxygen per minute. 
Vital signs and GCS of the patients were also 
measured and registered within 5 and 15 minutes 
after drug administration and at the time of arrival 
to the hospital.  
Outcome assessment 
VAS was used to measure pain intensity in patients. 
It has a domain of 0 to 10 scores with 0 
corresponding a non-painful condition and 10 
corresponding the highest conceivable amount of 
pain. VAS score was measured in two steps, at first 
VAS score was calculated before ketamine or 
morphine administration. In the second step it was 
calculated within 5 and 15 minutes and at the time 
of arrival to the hospital after receiving ketamine 
or morphine. This information was registered in 
checklists. A 50 percent decrease in VAS score or 
reaching to score 3 showed the succession of 
treatment. Patients were also asked if they were 
experiencing any side effects including nausea, 
vomiting, increased saliva secretion, hypotension, 
hallucination and agitation. 
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Statistical analysis 
All data were enrolled into SPSS software version 
24, variables were shown based on frequency and 
percentage or mean and standard division, 
Independent t test was used to compare 
quantitative variables between groups and Chi 
Square and fisher's exact test was used to compare 
qualitative variables between groups. Also 
repeated measure ANOVA was used to compare 
changing variables in times. P-value less than 0.05 
was considered significant. 
RESULTS 
Figure 1 shows the CONSORT flowchart of study 
patients. In the beginning 400 patients were 
included in the study and 391 of them were finally 
analysed. Patients were divided into two groups: 
morphine (196 patients) and ketamine (195 
patients). Three patients (1.5%) in morphine group 
and 14 patients (7.1%) in ketamine group had need 
more than two doses of analgesics, so excluded of 
final analysis. Baseline data of study patients are 
reported in table 1. Based on the findings, there 
was no significant difference between the two 
groups regarding their gender and age (P>0.05). 
Nineteen patients (9.6%) in morphine group and 
72 (36.9%) patients in ketamine group had need 
more than one dose of drugs There was also no 
significant difference in VAS before intervention, 5 
and 15 first minutes and the moment of admission 
in ER between the two groups (P>0.05), but 
according to repeated measure ANOVA test, the 
changing of VAS scores in different times was 
significant in both groups (P<0.001). Also, there 
were no significant differences of systolic and 
diastolic blood pressures, respiratory rate and 
heart rate before intervention, first 5 and 15 
minutes and at the time of admission in ER 
between the two groups (P>0.05); however, based 
on repeated measure ANOVA test, the changings of 
systolic and diastolic pressures, respiratory rate 
and heart rate were significant in different times in 
each group (P<0.001). Pain intensity and 
hemodynamic variables studied in the two groups 
at different times are reported in table 2. The 
incidence of nausea and vomiting was 27% (53 
 
Figure 1: CONSORT flowchart of study patients 
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cases) in the morphine group and 5.1% (10 cases) 
in the ketamine group, and the rate of delirium was 
1% (2 cases) in the morphine group and 5.6% (11 
cases) in the ketamine group. There was a 
significant difference between the two groups in 
complications including nausea and vomiting 
(P<0.001), and also delirium (P=0.010).  
DISCUSSION 
According to the results of this study, there was no 
difference between using morphine and ketamine 
in pain management in trauma patients before they 
were referred to the ER and there was no 
difference in the hemodynamic variables, but the 
rate of complications like nausea and vomiting was 
significantly higher in patients receiving morphine 
and the rate of delirium was significantly higher in 
patients receiving ketamine. As mentioned earlier, 
pain control is very important in patients especially 
in traumatized patients. In this study, by assessing 
ketamine nebulizer and IV morphine, we 
concluded that there is no significant difference 
between these two drugs in terms of pain control 
but they are different in terms of complications and 
side effects. Various studies have been conducted 
on this subject. In a 2015 study by Miller et al., They 
compared the effects of low-dose ketamine and 
morphine in trauma patients. In this study, 45 
patients were evaluated and finally it was reported 
that low doses of intravenous ketamine did not 
make a difference in patients' pain intensity 
compared to intravenous morphine. But on the 
other hand, they showed that the analgesic effects 
of ketamine started within 5 minutes and lasted for 
about 2 hours (8). The results of this study are 
consistent with the results of our study because we 
also showed that there was no difference between 
ketamine and morphine in terms of pain control. 
Table 1: Variables studied between the two groups 
Variable Morphine group Ketamine group P-value 
Age, mean±SD (years) 39.28 ± 9.53 39.57 ± 9.65 0.758* 
Gender, n(%) 
Male 126 (64.3%) 112 (57.4%) 
0.1** 
Female 70 (35.7%) 83 (42.6%) 
Primary pain intensity, n(%) (VAS) 
7 151 (77.4%) 143 (73.3%) 
0.47* 
8 39 (20%) 42 (21.5%) 
9 4 (2.1%) 6 (3.1%) 
10 1 (0.5%) 4 (2.1%) 




Table 2: Pain intensity and hemodynamic variables studied in two groups at different times 
Variable 
Morphine group Ketamine group 
P-value* 
Mean ± SD n Mean ± SD n 
Severity of pain Before intervention 7.25 ± 0.51 196 7.33 ± 0.64 195 0.164 
First 5 minutes 5.67 ± 0.92 196 5.73 ± 1.02 191 0.532 
First 15 minutes 4.68 ± 1.13 195 4.84 ± 1.25 186 0.173 
The moment of emergency 3.38 ± 1.23 193 3.53 ± 1.35 181 0.247 
P-value** <0.001 <0.001  
Systolic blood pressure Before intervention 125.20 ± 13.23 196 123.80 ± 13.86 195 0.314 
First 5 minutes 124.44 ± 13.09 196 123.59 ± 14.56 191 0.545 
First 15 minutes 124.76 ± 11.80 195 123.01 ± 16.22 186 0.227 
The moment of emergency 126.35 ± 11.24 193 125.20 ± 11.33 181 0.316 
P-value** <0.001 <0.001  
Diastolic blood pressure Before intervention 76.50 ± 7.35 196 78.26 ± 8.28 195 0.091 
First 5 minutes 80.44 ± 14.16 196 80.78 ± 13.74 191 0.810 
First 15 minutes 76.94 ± 8.27 195 79.85 ± 7.83 186 0.100 
The moment of emergency 81.73 ± 12.49 193 81.35 ± 13.25 181 0.778 
P-value** <0.001 <0.001  
Respiratory rate Before intervention 21.52 ± 3.85 196 23.10 ± 3.73 195 0.102 
First 5 minutes 19.42 ± 2.28 196 20.13 ± 2.53 191 0.233 
First 15 minutes 18.88 ± 2.36 195 19.40 ± 2.23 186 0.202 
The moment of emergency 19.23 ± 2.64 193 21.90 ± 3.33 181 0.155 
P-value** <0.001 <0.001  
Heart rate Before intervention 79.52 ± 12.48 196 80.28 ± 13.82 195 0.573 
First 5 minutes 77.39 ± 11.40 196 78.62 ± 12.83 191 0.331 
First 15 minutes 74.90 ± 10.56 195 75.82 ± 11.25 186 0.414 
The moment of emergency 74.44 ± 11.55 193 76.05 ± 13.46 181 0.211 
P-value** <0.001 <0.001  
*Independent t test, **Repeated measure ANOVA 
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However, in this study, we used ketamine 
nebulizers to reduce pain in patients and showed 
that they had fewer gastrointestinal complications 
than morphine. Another study by Tran et al in 2014 
assessed the effects of ketamine and morphine on 
pain relief in trauma patients. This study was 
conducted on 169 patients showing that ketamine 
and morphine act similarly in reducing pain and 
there is no difference between them in terms of 
pain control. It also showed that the risk of airway 
complications was lower in patients who received 
ketamine compared to those who were given 
morphine. In addition, they reported complications 
such as hallucination and agitation in patients 
receiving ketamine (6). These results are 
consistent with the results of our study as we also 
showed no difference in pain suppression between 
the ketamine and morphine groups and we also 
found that complications such as delirium were 
more frequent in patients receiving ketamine. In 
addition, the highlight of our study is the bigger 
statistical population than other studies as well as 
the use of ketamine nebulizers instead of 
intravenous ketamine. In a study by Majidinejad et 
al., comparing the analgesic effects of morphine 
and ketamine in 126 traumatic bone fracture 
patients it was concluded that low-dose ketamine 
administration was associated with significantly 
reduced pain in patients and that there was no 
difference in analgesic effects between patients 
receiving morphine or ketamine (9). This study, 
similar to previous studies, presented results 
consistent with our study, suggesting that there 
was no difference between morphine and ketamine 
in analgesic effects. Studies have also investigated 
the effects of simultaneous use of ketamine and 
morphine and have shown that ketamine use is 
associated with a decreased morphine 
requirement in patients with severe pain (10). 
Thus, studies are trying to find a way to reduce 
morphine use and patients' needs (11). 
Limitations 
The limitations of our study were included short 
period of the follow up and not evaluating other 
effective factors. Another important missed point 
was the subgroup analysis, considering the final 
diagnosis of trauma patients, for example, based on 
presence or absence of bone fractures. Such 
limitations and also numerous exclusion criteria in 
this trial, make it difficult to generalize the results. 
So further trials are still required in this regard. In 
contrast, providing a safe drug in the pre-hospital 
phase for pain control in trauma patients is a 
significant advantage of the present study. 
CONCLUSIONS 
According to the results of the current study, it is 
likely that using ketamine nebulizer can produce 
similar analgesic effects as IV morphine in trauma 
patients referred to ER. However, it is 
recommended to use ketamine with caution in 
patients with a history of psychiatric or 
psychological problems, as we have shown that 
delirium-like effects were more common in 
patients receiving ketamine. 
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